Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $13.35 Million |
|---|---|
| Enterprise Value | $12.85 Million |
| Earnings per Share | $-1.76 |
| Beta | 1.26 |
| Outstanding Shares | 2,768,506 |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | 2.4 |
| Enterprise Value to Revenue | 4.87 |
| Enterprise Value to EBIT | -1.15 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis an...